Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease

Supplemental Digital Content is available in the text. Background: Invasive hemodynamic evaluation through right heart catheterization plays an essential role in the diagnosis, categorization, and risk stratification of patients with pulmonary hypertension. Methods: Subjects enrolled in the PVDOMICS (Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics) program undergo an extensive invasive hemodynamic evaluation that includes repeated measurements at rest and during several provocative physiological challenges. It is a National Institutes of Health/National Heart, Lung, and Blood Institute initiative to reclassify pulmonary hypertension groups based on clustered phenotypic and phenomic characteristics. At a subset of centers, participants also undergo an invasive cardiopulmonary exercise test to assess changes in hemodynamics and gas exchange during exercise. Conclusions: When coupled with other physiological testing and blood -omic analyses involved in the PVDOMICS study, the comprehensive right heart catheterization protocol described here holds promise to clarify the diagnosis and clustering of pulmonary hypertension patients into cohorts beyond the traditional 5 World Symposium on Pulmonary Hypertension groups. This article will describe the methods applied for invasive hemodynamic characterization in the PVDOMICS program. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02980887.

[1]  F. Martinez,et al.  Pulmonary hypertension in chronic lung disease and hypoxia , 2019, European Respiratory Journal.

[2]  S. Rosenkranz,et al.  Pulmonary hypertension due to left heart disease , 2019, European Respiratory Journal.

[3]  Paul G. Williams,et al.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.

[4]  V. Melenovský,et al.  Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction. , 2018, JACC. Heart failure.

[5]  S. Rosenkranz,et al.  Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Controversies and Practical Issues. , 2018, Heart failure clinics.

[6]  F. Harrell,et al.  Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension , 2017, JAMA cardiology.

[7]  R. Chatburn,et al.  Impact of Intrathoracic Pressure in the Assessment of Pulmonary Hypertension in Overweight Patients , 2017, Annals of the American Thoracic Society.

[8]  W. Chung,et al.  PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics. , 2017, Circulation research.

[9]  S. Resch,et al.  Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center , 2017, European journal of preventive cardiology.

[10]  A. Waxman,et al.  Pulmonary haemodynamics during recovery from maximum incremental cycling exercise , 2016, European Respiratory Journal.

[11]  G. Grunwald,et al.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program , 2016, Circulation.

[12]  Natalia C. Berry,et al.  Protocol for Exercise Hemodynamic Assessment: Performing an Invasive Cardiopulmonary Exercise Test in Clinical Practice , 2015, Pulmonary circulation.

[13]  V. Melenovský,et al.  Differential Hemodynamic Effects of Exercise and Volume Expansion in People With and Without Heart Failure , 2015, Circulation. Heart failure.

[14]  J. Newman,et al.  High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension , 2014, Circulation. Heart failure.

[15]  N. Westerhof,et al.  Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects , 2013, European Respiratory Journal.

[16]  H. Olschewski,et al.  Zero reference level for right heart catheterisation , 2013, European Respiratory Journal.

[17]  B. Maron,et al.  The Invasive Cardiopulmonary Exercise Test , 2013, Circulation.

[18]  Yuhui Zhang,et al.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. , 2013, Chest.

[19]  G. Lewis,et al.  Pulmonary Vascular Response Patterns During Exercise in Left Ventricular Systolic Dysfunction Predict Exercise Capacity and Outcomes , 2011, Circulation. Heart failure.

[20]  R. Nishimura,et al.  Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction , 2010, Circulation. Heart failure.

[21]  R. Krasuski,et al.  Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. , 2000, Journal of the American College of Cardiology.

[22]  K. Wasserman,et al.  Impact of integrative cardiopulmonary exercise testing on clinical decision making. , 1991, Chest.

[23]  Mosteller Rd Simplified Calculation of Body-Surface Area , 1987 .

[24]  R. Mosteller Simplified calculation of body-surface area. , 1987, The New England journal of medicine.